Study Finds Flu Vaccines Often Fall Short of Estimates

A University of Maryland analysis of 18 flu seasons found vaccine effectiveness frequently lands below the commonly cited 40% to 60% range.

Updated on Nov. 20, 2026 in Diseases — General

Clear glass vaccine vial and plain syringe on a pale steel clinical tray in a softly lit, neutral clinic interior.
Researchers at the University of Maryland report that flu vaccines have often been less effective than the 40% to 60% range officials commonly cite, with a median of 39.5% across 18 seasons. AI Illustration. Upload story photo >

Live Poll

Do you think the flu shot protects you as well as health officials claim?

Researchers from the University of Maryland report in JAMA Network Open that flu vaccine effectiveness has often been lower than officials commonly cite. Across the 18 seasons studied, the median effectiveness in preventing infection was 39.5%.

Why it matters

Vaccine effectiveness estimates shape public expectations about how much protection a flu shot provides each year. The findings also suggest that a mismatch between the vaccine and circulating strains is a recurring factor in weaker performance.

The analysis covers flu seasons from 2004-2005 through 2023-2024 and reports a median vaccine effectiveness of 39.5% against infection, below the commonly cited 40% to 60% range. The researchers did not identify every factor behind the variation across seasons.

The players

University of Maryland

A public research university whose researchers conducted the analysis of flu vaccine effectiveness across multiple seasons.

Centers for Disease Control and Prevention (CDC)

The U.S. federal public health agency that tracks flu deaths, hospitalizations and vaccination benefits nationwide.

The details

The researchers analyzed end-of-season effectiveness estimates and also assessed whether each season's vaccine was well matched to the flu strains that actually circulated. Higher effectiveness estimates are often tied to a good match, and the new data is hoped to spur research into influenza vaccines offering broader protection.

Timeline

  1. 2004-2005: First flu season included in the vaccine effectiveness analysis.

  2. 2023-2024: Last flu season included in the analysis.

  3. Nov. 10, 2026: Study published in JAMA Network Open.

  4. Nov. 16, 2026: University of Maryland news release issued.

Health Landscape

The analysis puts pressure on the CDC's annual flu vaccine effectiveness estimates, which are used to set public expectations each season. It also adds to the research push toward influenza vaccines that match circulating strains more reliably.

Flu vaccines remain the main tool available to reduce severe illness, with CDC estimates attributing 120,000 prevented hospitalizations to vaccination in the 2023-2024 season. Because effectiveness varies from season to season, the study suggests a flu shot's protection is not guaranteed to reach the highest estimates each year.

The takeaway

A flu shot still prevents substantial illness even in seasons when its effectiveness is modest, so annual vaccination remains worthwhile. Expect protection to vary by year depending on how well the vaccine matches circulating strains.

Further reading

Explore more on Diseases — General for broader context on flu and other infectious illnesses.

Source note: This article includes information reported by U.S. News & World Report.

Live Poll

Do you think the flu shot protects you as well as health officials claim?